Skip to content

Clinical trials

Trials in Austria with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Status: Unknown status Country / region: Austria Clear all

709 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20012
20025
20032
20048
20054
200612
200717
200825
200929
201031
201131
201235
201327
201431
201524
201634
201746
201853
201952
202070
202159
202243
202338
202415

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status709

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medical University of Vienna258
Medical University of Graz54
Medical University Innsbruck41
Vienna Institute for Research in Ocular Surgery25
Prim. Prof. Dr. Oliver Findl, MBA20
University of Vienna13
European Organisation for Research and Treatment of Cancer - EORTC9
Johannes Kepler University of Linz9
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery6
St. Anna Kinderkrebsforschung5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cataract34
COVID-1917
Coronary Artery Disease15
Macular Degeneration15
Pulmonary Disease, Chronic Obstructive13
Heart Failure12
Peripheral Arterial Disease11
Cardiovascular Diseases10
Diabetes Mellitus10
Diabetes Mellitus, Type 29

Trials

Showing 51 to 75 of 709. Each trial links to its page on Pharma Observatory.

609 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.